Annual EBITDA
$4.25B$411.00M-8.83%
Summary
- Current Value
- As of today, REGN annual EBITDA is $4.25B, down -8.83% on
- Historical Performance
- REGN annual EBITDA is down -25.87% over the past 3 years, up +11.36% over the past 5 years
- All-Time High Comparison
- REGN annual EBITDA is currently -54.02% below its historical high of $9.23B set on
- 3-Year Low Comparison
- REGN annual EBITDA is at its 3-year low
- Sector Comparison
- REGN annual EBITDA is higher than 97.35% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $4.25B | -8.8% | -25.9% | +11.4% | +5558.3% | |
| Quarterly EBITDA | $1.54B | +26.1% | +37.9% | -54.8% | +3046.0% | |
| TTM EBITDA | $4.70B | +5.3% | -5.1% | -32.2% | +4008.5% | |
| Price | $840.84 | +47.1% | +3.5% | +28.3% | +1446.5% | |
| PE Ratio | 20.78 | +44.2% | -3.2% | +76.5% | – | |
| Annual Revenue | $14.34B | +1.0% | +17.8% | +68.8% | +3024.3% | |
| Annual EPS | $41.48 | +8.2% | +8.5% | +35.9% | +3392.2% | |
| $3.69B | -11.5% | -31.4% | +3.3% | +3888.6% | ||
| Annual Net Income | $4.50B | +2.1% | +3.8% | +28.2% | +4412.2% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $5.73B | N/A | -25.9% |
| 5Y | $9.23B | -54.0% | |
| All | $9.23B | -54.0% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $4.25B | at low | |
| 5Y | $3.81B | N/A | +11.4% |
| All | -$174.08M | +2539.0% |
EBITDA History
FAQ
- What is the current annual EBITDA of REGN?
- As of today, REGN annual EBITDA is $4.25B
- What is 1-year change in REGN annual EBITDA?
- REGN annual EBITDA is down -8.83% year-over-year
- What is 3-year change in REGN annual EBITDA?
- REGN annual EBITDA is down -25.87% over the past 3 years
- How far is REGN annual EBITDA from its all-time high?
- REGN annual EBITDA is currently -54.02% below its historical high of $9.23B set on December 31, 2021
- How does REGN annual EBITDA rank versus sector peers?
- REGN annual EBITDA is higher than 97.35% of companies in Healthcare sector
- When is REGN next annual earnings release?
- As of today, the next annual earnings release for REGN has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$1.54B$676.20M+77.90%
Summary
- Current Value
- As of today, REGN quarterly EBITDA is $1.54B, up +77.90% on
- Historical Performance
- REGN quarterly EBITDA is up +26.10% year-over-year, up +37.92% over the past 3 years
- All-Time High Comparison
- REGN quarterly EBITDA is currently -54.83% below its historical high of $3.42B set on
- 3-Year Low Comparison
- REGN quarterly EBITDA is +111.27% above its 3-year low of $730.90M reached on
- Sector Comparison
- REGN quarterly EBITDA is higher than 97.44% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $1.54B | +77.9% | +26.1% | +37.9% | -54.8% | |
| Annual EBITDA | $4.25B | – | -8.8% | -25.9% | +11.4% | |
| TTM EBITDA | $4.70B | +7.3% | +5.3% | -5.1% | -32.2% | |
| Price | $840.84 | +33.4% | +47.1% | +3.5% | +28.3% | |
| PE Ratio | 20.78 | +35.3% | +44.2% | -3.2% | +76.5% | |
| Quarterly Revenue | $4.29B | +19.0% | +16.7% | +35.9% | -16.5% | |
| Quarterly EPS | $12.23 | +81.2% | -4.5% | +43.9% | -56.3% | |
| $1.42B | +90.7% | +30.4% | +39.7% | -57.6% | ||
| Quarterly Net Income | $1.30B | +78.3% | -6.8% | +33.9% | -58.1% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $1.54B | at high | |
| 3Y | $1.54B | at high | |
| 5Y | $3.42B | N/A | -54.8% |
| All | $3.42B | -54.8% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $868.00M | +77.9% | |
| 3Y | $730.90M | +111.3% | |
| 5Y | $730.90M | +111.3% | |
| All | -$52.42M | +3046.0% |
Quarterly EBITDA History
FAQ
- What is the current quarterly EBITDA of REGN?
- As of today, REGN quarterly EBITDA is $1.54B
- What is REGN quarterly EBITDA most recent change?
- REGN quarterly EBITDA was up +77.90% on June 30, 2026
- What is 1-year change in REGN quarterly EBITDA?
- REGN quarterly EBITDA is up +26.10% year-over-year
- How far is REGN quarterly EBITDA from its all-time high?
- REGN quarterly EBITDA is currently -54.83% below its historical high of $3.42B set on June 30, 2021
- How does REGN quarterly EBITDA rank versus sector peers?
- REGN quarterly EBITDA is higher than 97.44% of companies in Healthcare sector
- When is REGN next earnings release?
- The next earnings release for REGN is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$4.70B$319.60M+7.29%
Summary
- Current Value
- As of today, REGN TTM EBITDA is $4.70B, up +7.29% on
- Historical Performance
- REGN TTM EBITDA is up +5.30% year-over-year, down -5.07% over the past 3 years
- All-Time High Comparison
- REGN TTM EBITDA is currently -50.05% below its historical high of $9.41B set on
- 3-Year Low Comparison
- REGN TTM EBITDA is +10.76% above its 3-year low of $4.25B reached on
- Sector Comparison
- REGN TTM EBITDA is higher than 97.25% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $4.70B | +7.3% | +5.3% | -5.1% | -32.2% | |
| Annual EBITDA | $4.25B | – | -8.8% | -25.9% | +11.4% | |
| Quarterly EBITDA | $1.54B | +77.9% | +26.1% | +37.9% | -54.8% | |
| Price | $840.84 | +33.4% | +47.1% | +3.5% | +28.3% | |
| PE Ratio | 20.78 | +35.3% | +44.2% | -3.2% | +76.5% | |
| TTM Revenue | $15.53B | +4.1% | +9.3% | +22.6% | +25.4% | |
| TTM EPS | $40.46 | -1.4% | +1.9% | +6.9% | -27.4% | |
| $4.17B | +8.6% | +5.5% | -8.4% | -37.5% | ||
| TTM Net Income | $4.33B | -2.1% | -2.9% | +0.7% | -30.2% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $4.70B | at high | |
| 3Y | $4.95B | -5.1% | |
| 5Y | $9.41B | -50.0% | |
| All | $9.41B | -50.0% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $4.25B | +10.8% | |
| 3Y | $4.25B | +10.8% | |
| 5Y | $4.25B | +10.8% | |
| All | -$174.08M | +2801.3% |
TTM EBITDA History
FAQ
- What is the current TTM EBITDA of REGN?
- As of today, REGN TTM EBITDA is $4.70B
- What is REGN TTM EBITDA most recent change?
- REGN TTM EBITDA was up +7.29% on June 30, 2026
- What is 1-year change in REGN TTM EBITDA?
- REGN TTM EBITDA is up +5.30% year-over-year
- How far is REGN TTM EBITDA from its all-time high?
- REGN TTM EBITDA is currently -50.05% below its historical high of $9.41B set on March 31, 2022
- How does REGN TTM EBITDA rank versus sector peers?
- REGN TTM EBITDA is higher than 97.25% of companies in Healthcare sector
- When is REGN next earnings release?
- The next earnings release for REGN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- REGN Official Website www.regeneron.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/872589/000087258926000008/0000872589-26-000008-index.htm
- REGN Profile on Yahoo Finance finance.yahoo.com/quote/REGN
- REGN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/regn